First Turn Management »

Sarepta Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 204k 96.43

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics